UY25443A1 - Procedimiento para la preparacion de principio activo peroral - Google Patents

Procedimiento para la preparacion de principio activo peroral

Info

Publication number
UY25443A1
UY25443A1 UY25443A UY25443A UY25443A1 UY 25443 A1 UY25443 A1 UY 25443A1 UY 25443 A UY25443 A UY 25443A UY 25443 A UY25443 A UY 25443A UY 25443 A1 UY25443 A1 UY 25443A1
Authority
UY
Uruguay
Prior art keywords
preparation
procedure
active principle
small amounts
peroral
Prior art date
Application number
UY25443A
Other languages
English (en)
Inventor
Dietrich Türck Dr
Veit Schmelmer Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of UY25443A1 publication Critical patent/UY25443A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a procedimiento para la preparación de suspensiones aplicables por vía oral de principios activos farmacéuticos del tipo FNEAI (fármacos no esteroides-anti-inflamatorios), en particular del agente antirreumático Meloxicam, que son estabilizadas mediante incorporación de pequeñas cantidades de dióxido de silicio muy disperso con ayuda de elevadas fuerzas de cizallamiento y adición de pequeñas cantidades de polímeros hidrófilos bajo formación de una estructura siloide tridimensional.
UY25443A 1998-03-27 1999-03-24 Procedimiento para la preparacion de principio activo peroral UY25443A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension

Publications (1)

Publication Number Publication Date
UY25443A1 true UY25443A1 (es) 1999-11-17

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25443A UY25443A1 (es) 1998-03-27 1999-03-24 Procedimiento para la preparacion de principio activo peroral

Country Status (26)

Country Link
EP (2) EP0945131A1 (es)
JP (1) JP3323189B2 (es)
KR (1) KR100587208B1 (es)
CN (1) CN1150888C (es)
AR (1) AR016196A1 (es)
AT (1) ATE225648T1 (es)
AU (1) AU762464B2 (es)
BR (1) BR9909189A (es)
CA (1) CA2326048C (es)
CO (1) CO5070601A1 (es)
DE (1) DE59903023D1 (es)
DK (1) DK1066029T3 (es)
ES (1) ES2184428T3 (es)
HK (1) HK1034184A1 (es)
HU (1) HU228474B1 (es)
IL (1) IL137479A (es)
MY (1) MY124599A (es)
NO (1) NO321401B1 (es)
NZ (1) NZ507610A (es)
PL (1) PL192969B1 (es)
PT (1) PT1066029E (es)
TR (1) TR200002772T2 (es)
TW (1) TWI232759B (es)
UY (1) UY25443A1 (es)
WO (1) WO1999049845A1 (es)
ZA (1) ZA200003951B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
CA2521603A1 (en) * 2003-04-07 2004-10-21 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
PT1824493E (pt) 2004-12-06 2008-11-18 Janssen Pharmaceutica Nv Suspensão oral que compreende meloxicam
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
WO2011110930A2 (en) * 2010-03-10 2011-09-15 Lupin Limited Rifaximin ready-to-use suspension
CA2959951A1 (en) * 2010-03-19 2011-09-22 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
CN104854411B (zh) * 2012-12-19 2017-06-13 三菱电机株式会社 空调机
RU2749423C2 (ru) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Способ получения стерилизованного влажного кормового продукта для домашних животных
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
HUP0102036A2 (hu) 2002-03-28
CO5070601A1 (es) 2001-08-28
WO1999049845A1 (de) 1999-10-07
CA2326048C (en) 2008-08-12
ATE225648T1 (de) 2002-10-15
NO20004822L (no) 2000-11-23
EP1066029A1 (de) 2001-01-10
PT1066029E (pt) 2003-02-28
NO20004822D0 (no) 2000-09-26
DK1066029T3 (da) 2003-01-27
AU762464B2 (en) 2003-06-26
CN1295462A (zh) 2001-05-16
EP1066029B1 (de) 2002-10-09
ZA200003951B (en) 2002-01-18
JP3323189B2 (ja) 2002-09-09
HK1034184A1 (en) 2001-10-19
BR9909189A (pt) 2000-12-05
AR016196A1 (es) 2001-06-20
NZ507610A (en) 2003-08-29
KR20010042197A (ko) 2001-05-25
TR200002772T2 (tr) 2000-12-21
JP2002509875A (ja) 2002-04-02
HU228474B1 (en) 2013-03-28
DE59903023D1 (en) 2002-11-14
IL137479A (en) 2005-09-25
TWI232759B (en) 2005-05-21
HUP0102036A3 (en) 2002-12-28
AU3147099A (en) 1999-10-18
KR100587208B1 (ko) 2006-06-08
MY124599A (en) 2006-06-30
CA2326048A1 (en) 1999-10-07
CN1150888C (zh) 2004-05-26
PL342345A1 (en) 2001-06-04
NO321401B1 (no) 2006-05-08
IL137479A0 (en) 2001-07-24
EP0945131A1 (de) 1999-09-29
PL192969B1 (pl) 2006-12-29
ES2184428T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
UY25443A1 (es) Procedimiento para la preparacion de principio activo peroral
HUP0204110A2 (hu) Amfifil prodrugok, eljárás az ezeket tartalmazó gyógyszerkészítmények előállítására és alkalmazására
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
CO4480020A1 (es) Formulaciones farmaceuticas
BR0212475A (pt) Composições farmacêuticas
BR9908488A (pt) Composição farmacêutica de topiramato
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
PT1283700E (pt) Composicoes farmaceuticas de libertacao prolongada destinadas a administracao por via parental de compostos hidrofilos biologicamente activos
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
PE3296A1 (es) Composicion oral conteniendo un mucoadhesivo
ATE418324T1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
BR9901782A (pt) Forma para dosagem de nefazodona.
BRPI0009299A (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
CO5140079A1 (es) Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
AR036747A1 (es) Productos para la axila, con componente de bloque de agua
ECSP045029A (es) Composiciones de valdecoxib de disgregación intraoral
ES2344730T3 (es) Composicion farmacologica para administracion nasal de fentanilo.
JP2005298448A (ja) アズレン含有水性液剤
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
BR9917220A (pt) Composição para gomas de mascarmedicamentosas, processo para produção damesma, e tabletes assim obtidos
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
ITMI20010913A1 (it) Composizioni a rilascio controllato di acido lattico a livello vaginale
CN115038451A (zh) 多模式组合物和治疗方法

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20190324